List of Excipients in Branded Drug CETIRIZINE

Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
TARGET Corporation	CETIRIZINE HCL	cetirizine hcl	11673-242	FD&C YELLOW NO. 6
TARGET Corporation	CETIRIZINE HCL	cetirizine hcl	11673-242	GELATIN
TARGET Corporation	CETIRIZINE HCL	cetirizine hcl	11673-242	GLYCERIN
TARGET Corporation	CETIRIZINE HCL	cetirizine hcl	11673-242	MANNITOL
TARGET Corporation	CETIRIZINE HCL	cetirizine hcl	11673-242	POLYETHYLENE GLYCOL
TARGET Corporation	CETIRIZINE HCL	cetirizine hcl	11673-242	SODIUM HYDROXIDE

Generic Drugs Containing CETIRIZINE

Company	Ingredient	NDC	Excipient
Walgreens	cetirizine	0363-1040	1,4-SORBITAN
Walgreens	cetirizine	0363-1040	BUTYLATED HYDROXYTOLUENE
Walgreens	cetirizine	0363-1040	GELATIN
Walgreens	cetirizine	0363-1040	GLYCERIN
Walgreens	cetirizine	0363-1040	MANNITOL
Walgreens	cetirizine	0363-1040	POLYETHYLENE GLYCOL 400

What are the Most Frequently-Used Excipients in CETIRIZINE?

# Of NDCs	Excipient
4	1,4-SORBITAN
1	ACETIC ACID
1	AMMONIA N-13
1	BLUE 1
1	BUTYL ALCOHOL
4	BUTYLATED HYDROXYTOLUENE

Excipient Strategy and Commercial Opportunities for Cetirizine

Last updated: March 1, 2026

What are the key excipient considerations in Cetirizine formulation?

Cetirizine is an antihistamine used in allergic rhinitis and chronic urticaria. Its formulation involves excipients that influence bioavailability, stability, manufacturing processes, and patient compliance. The primary excipients include binders, fillers, disintegrants, lubricants, and flavoring agents.

Common excipients in Cetirizine tablets are:

• Lactose monohydrate: Serves as a filler and binder, facilitating tablet formation.
• Microcrystalline cellulose: Acts as a binder and disintegrant.
• Povidone (PVP): Used as a binder, promoting tablet cohesion.
• Magnesium stearate: Lubricant reducing friction during manufacturing.
• Flavoring agents: Enhance taste for oral formulations.
• Colorants: Improve aesthetic appeal.

In liquid formulations, excipients such as glycerol and parabens are incorporated for stability and preservation.

How does excipient selection impact bioavailability and stability?

Excipient choice affects particle size, dissolution rate, and chemical stability. For Cetirizine, rapid dissolution improves onset of action, which is desirable for antihistamines.

Lactose, while widely used, can cause issues in lactose-intolerant patients. Alternatives like microcrystalline cellulose or mannitol are considered. Povidone enhances solubility but must be balanced against potential stability concerns.

Excipients influence shelf life; for example, moisture-sensitive excipients can accelerate degradation. Formulation strategies include incorporating desiccants and using moisture-resistant packaging.

What are the manufacturing and regulatory considerations?

Regulatory agencies require excipients to meet pharmacopeial standards. Excipients must be pharmaceutically acceptable, non-toxic, and consistent batch-to-batch.

Manufacturers evaluate excipient compatibility with active ingredients. Process parameters—such as compression force and mixing time—are optimized to ensure tablet quality.

Novel excipients or formulations may require additional testing and regulatory approval. This can delay product launches but may provide competitive advantages.

What are commercial opportunities in excipient development?

Enhanced formulations targeting patient compliance can expand market share. Examples include:

• Taste-masked formulations for pediatric use, requiring specialized flavoring agents and coating technologies.
• Rapid-dissolving tablets with superdisintegrants improve patient experience, especially for the elderly or those with swallowing difficulties.
• Excipient innovation, such as using natural or biocompatible excipients, caters to increasing demand for clean-label products.

Custom excipient systems offer patentability and differentiation. Partnering with excipient suppliers that develop tailored systems can streamline development timelines.

What trends influence excipient strategy in Cetirizine products?

• Patient-centric design: Focus on palatability and ease of administration.
• Regulatory shifts: Stricter controls on excipient labeling and allergen content.
• Sustainability: Preference for biodegradable and plant-based excipients.
• Biopharmaceutical advancements: Moving toward bioavailability-enhancing excipients.

Manufacturers leverage these trends to create innovative Cetirizine products suited for diverse markets.

What are the market implications?

The global antihistamine market was valued at approximately USD 3.6 billion in 2021, with Cetirizine accounting for a significant share (Grand View Research, 2022). Excipient innovation directly influences product differentiation, pricing strategies, and access in emerging markets.

Patents on formulations with novel excipients can extend exclusivity. The increasing focus on child-friendly and allergy-specific formulations opens niche opportunities.

Suppliers providing high-quality, customizable excipients can establish strategic partnerships, expanding their market footprint.

Key Takeaways

• Excipient selection in Cetirizine affects bioavailability, stability, and patient compliance.
• Formulation innovations include taste masking, rapid disintegration, and natural excipients.
• Regulatory compliance and process optimization are critical in excipient strategy.
• Market opportunities revolve around personalized and sustainable formulations.
• Partnerships with excipient suppliers can accelerate innovation and commercialization.

FAQs

1. What excipients are most commonly used in Cetirizine tablets?

Lactose monohydrate, microcrystalline cellulose, povidone, and magnesium stearate.

2. How does excipient choice influence Cetirizine's bioavailability?

It impacts dissolution rate and absorption, with soluble binders like povidone enhancing bioavailability.

3. What are the regulatory challenges associated with excipient selection?

Ensuring excipients meet pharmacopeial standards, are non-toxic, and compatible with the active ingredient.

4. How can excipient innovation create commercial advantages?

By enabling tailored formulations like taste-masked or fast-dissolving tablets, which appeal to specific patient groups.

5. What trends are shaping excipient strategies in this sector?

Patient-centric design, regulatory evolution, sustainability, and bioavailability enhancement.

References

1. Grand View Research. (2022). Antihistamines Market Size, Share & Trends Analysis. [online] Available at: https://www.grandviewresearch.com/industry-analysis/antihistamines-market [Accessed 23 Feb 2023].

2. U.S. Food and Drug Administration. (2020). Guidance for Industry: Nonclinical and Clinical Pharmacology and Biopharmaceutics Data to Support a Show of Bioequivalence. FDA.gov.

3. European Medicines Agency. (2021). Guideline on Excipients in the Dossier for Application for Marketing Authorization of a Medicine. EMA.europa.eu.

Note: Additional references are available based on specific formulation development and regulatory frameworks.